הכנס השנתי ה-27 של החברה לחקר, מניעה וטיפול בטרשת עורקים | 07-09/09/2023 בים המלח

Welcome

Keynote lecture: lipid Guidelines, currents status and future directions – Alberico L. Catapano

Lyso-DGTS, a novel bioactive lipid isolated from Nannochloropsis microalgae, Improved HDL functions and increased PON1 activities – Soliman Khatib

From mammalian haploid genetics to human lipoprotein metabolism: SPRING is a novel regulator of hepatic lipid metabolism – Noam Zelcer

Targeting the residual inflammatory risk in atherosclerosis: a case for colchicine – Yehuda Kamari

How much primary prevention of atherosclerosis is really primary? – Rom Keshet

The endosomal sorting complex retromer has a central role in cholesterol homeostasis by controlling the functioning of the lysosomal proteins LAL, scarb2 and npc1 – Bart van de Sluis

Triglyceride-rich lipoprotein remnants as a new therapeutic target for cardiovascular risk reduction – Alexandros Tselepis

EPA Therapy in patients at high CV risk – Gideon Paul

Atherosclerosis viewed from the inside – Elad Asher

Endothelial Extracellular Vesicles as Cellular Rescue Packages – Moran Yadid

Is it time to consider a paradigm shift for lipid lowering during an acute coronary syndrome? – Dov Gavish

Effect of EPA-lactone derivative on MCT-pulmonary arterial hypertension – Karthik Dhananjayan

Overnutrition causes insulin-dependent de-novo lipogenic pathways to become overactive in liver yet underactive in endothelium: a novel parallel signaling pathway unique to liver via insr-tc10-pi3kc2γ-pdpk1 – Kevin Williams

Dyslipidemia and Atherosclerosis in Oncology Patients & Cardio-Oncology Relevance – Dan Gilon

Environment and Health. What Clinicians Should Know? – Victor Novack

The effect of cannabis on cardiovascular disease – Ran Abuhasira

GLP-1 RA in T2D and ASCVD Patients- Gender differences and when is early enough? – Ronen Durst

Familial Hypercholesterolemia. Gaining decades of healthy life years by early detection and treatment – Albert Wiegman